Literature DB >> 27901576

The High Frequency of PIK3CA Mutations in Iranian Breast Cancer Patients.

Ghasem Azizi Tabesh1, Pantea Izadi1, Forouzandeh Fereidooni2, Amir Nader Emami Razavi2, Javad Tavakkoly Bazzaz1.   

Abstract

In breast cancer, somatic mutations of PIK3CA oncogene are common. We investigated the mutational status of exons 9 and 20 of the PIK3CA gene by polymerase chain reaction and direct sequencing in 80 breast tumors, and observed that 45% of these contained PIK3CA mutations in the mentioned exons. These mutations were found more in progesterone receptor positive and Her2- tumors, but this association did not reach a statistically significant level. Also, we observed a significant association between PIK3CA mutations and low-grade tumors. In our study, PIK3CA mutations were related to good and moderate prognosis in breast cancer patients.

Entities:  

Keywords:  Breast cancer; PIK3CA; somatic mutation

Mesh:

Substances:

Year:  2016        PMID: 27901576     DOI: 10.1080/07357907.2016.1247455

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  7 in total

Review 1.  Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention.

Authors:  Zahra Fathi; Nicholas L Syn; Jian-Guo Zhou; Raheleh Roudi
Journal:  J Hum Genet       Date:  2018-04-18       Impact factor: 3.172

2.  Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma.

Authors:  Munmee Dutta; Hidewaki Nakagawa; Hiroaki Kato; Kazuhiro Maejima; Shota Sasagawa; Kaoru Nakano; Aya Sasaki-Oku; Akihiro Fujimoto; Raúl Nicolás Mateos; Ashwini Patil; Hiroko Tanaka; Satoru Miyano; Takushi Yasuda; Kenta Nakai; Masashi Fujita
Journal:  PeerJ       Date:  2020-06-26       Impact factor: 2.984

3.  Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.

Authors:  Guoli Li; Xinwu Guo; Ming Chen; Lili Tang; Hui Jiang; Julia X Day; Yueliang Xie; Limin Peng; Xunxun Xu; Jinliang Li; Shouman Wang; Zhi Xiao; Lizhong Dai; Jun Wang
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

4.  The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials.

Authors:  Gao Chanchan; Su Xiangyu; Shi Fangfang; Chen Yan; Gu Xiaoyi
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

5.  The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China.

Authors:  Haibo Wu; Wei Wang; Jun Du; Hong Li; Huogang Wang; Liangliang Huang; Hang Xiang; Jing Xie; Xiaoli Liu; Heng Li; Wenchu Lin
Journal:  Cancer Manag Res       Date:  2019-02-14       Impact factor: 3.989

Review 6.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

7.  Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern.

Authors:  Ying-Zi Li; Bo Chen; Xiao-Yi Lin; Guo-Chun Zhang; Jian-Guo Lai; Cheukfai Li; Jia-Li Lin; Li-Ping Guo; Wei-Kai Xiao; Hsiaopei Mok; Chong-Yang Ren; Ling-Zhu Wen; Fang-Rong Cao; Xin Lin; Xiao-Fang Qi; Yang Liu; Ning Liao
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.